Mediators and clinical treatment for cancer cachexia: a systematic review
Abstract Background Cachexia, a complex multi‐organ syndrome, shortens survival time of patients, particularly those with cancer. Many studies and clinical trials have been carried out to identify cachexia‐inducing factors and potential treatments for cancer cachexia over the last 20 years. Of these...
Main Authors: | Zhipeng Cao, Andrew M. Scott, Nick J. Hoogenraad, Laura D. Osellame |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-07-01
|
Series: | JCSM Rapid Communications |
Subjects: | |
Online Access: | https://doi.org/10.1002/rco2.30 |
Similar Items
-
Cancer cachexia: lessons from Drosophila
by: Ying Liu, et al.
Published: (2022-03-01) -
Biomarkers for Cancer Cachexia: A Mini Review
by: Zhipeng Cao, et al.
Published: (2021-04-01) -
One-Year Mortality in Patients with Cancer Cachexia: Association with Albumin and Total Protein
by: Liu XY, et al.
Published: (2021-08-01) -
Cancer Cachexia: Muscle Physiology and Exercise Training
by: Matthew L. Goodwin, et al.
Published: (2012-11-01) -
Identification of Potential Biomarkers for Cancer Cachexia and Anti-Fn14 Therapy
by: Zhipeng Cao, et al.
Published: (2022-11-01)